Wildcat Capital Management, LLC Portfolio Holdings

Wildcat Capital Management, LLC has filed its 13F form on May 02, 2025 for Q1 2025 where it was disclosed a total value porftolio of $171 Million distributed in 8 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Frontier Group Holdings, Inc. with a value of $122M, Rlx Technology Inc. with a value of $33.9M, Uro Gen Pharma Ltd. with a value of $5.48M, Allogene Therapeutics, Inc. with a value of $4.26M, and Centessa Pharmaceuticals PLC with a value of $4.05M.

Examining the 13F form we can see an decrease of $81.9M in the current position value, from $252M to 171M.

Below you can find more details about Wildcat Capital Management, LLC portfolio as well as his latest detailed transactions.